Eli Lilly shares briefly drop after tweet by senator - Sanders say Lilly, Novo Nordisk making ‘outrageous profits’ Makers of insulin became the latest target for Senator Bernie Sanders, who has been going after pharmaceutical companies one by one over the issue of high U.S. drug prices.
Shares of Eli Lilly & Co. fell after the senator, an independent lawmaker from Vermont, criticized the company and Novo Nordisk A/S over the price of insulin. Read more.
Bloomberg
Related,
- Bernie Sanders is attacking insulin makers for their price hikes - particularly Novo Nordisk and Eli Lilly - Business Insider
- Bernie Sanders wants the feds to investigate these drug companies for possible price collusion - Washington Post
No comments:
Post a Comment